A detailed history of United Services Automobile Association transactions in Abb Vie Inc. stock. As of the latest transaction made, United Services Automobile Association holds 449,905 shares of ABBV stock, worth $79 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares
449,905
Previous 612,263 26.52%
Holding current value
$79 Million
Previous $105 Million 15.4%
% of portfolio
2.29%
Previous 2.68%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $26.6 Million - $32.4 Million
-162,358 Reduced 26.52%
449,905 $88.8 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $1.01 Million - $1.18 Million
-6,531 Reduced 1.06%
612,263 $105 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $4.46 Million - $5.09 Million
27,931 Added 4.73%
618,794 $113 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $41.3 Million - $46.6 Million
300,424 Added 103.44%
590,863 $91.6 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.84 Million - $2.13 Million
13,800 Added 4.99%
290,439 $43.3 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $23,454 - $29,187
177 Added 0.06%
276,639 $37.3 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $53.7 Million - $61.8 Million
-371,343 Reduced 57.32%
276,462 $44.1 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $4.05 Million - $4.86 Million
-29,271 Reduced 4.32%
647,805 $105 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3.22 Million - $3.7 Million
-24,007 Reduced 3.42%
677,076 $90.9 Million
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $9.87 Million - $12.5 Million
71,712 Added 11.39%
701,083 $107 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $36.7 Million - $45.6 Million
-278,190 Reduced 30.65%
629,371 $102 Million
Q4 2021

Feb 16, 2022

SELL
$107.43 - $135.93 $2.2 Million - $2.79 Million
-20,498 Reduced 2.21%
907,561 $123 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.37 Million - $2.69 Million
22,239 Added 2.46%
928,059 $100 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $37.4 Million - $41.7 Million
355,360 Added 64.56%
905,820 $102 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $14.2 Million - $15.6 Million
138,552 Added 33.64%
550,460 $59.6 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $1.07 Million - $1.44 Million
-13,261 Reduced 3.12%
411,908 $44.1 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $3.44 Million - $4.03 Million
-39,989 Reduced 8.6%
425,169 $37.2 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $6.26 Million - $8.38 Million
-85,339 Reduced 15.5%
465,158 $45.7 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $3.87 Million - $5.86 Million
59,974 Added 12.23%
550,497 $42.2 Million
Q4 2019

Jan 14, 2020

BUY
$72.13 - $90.25 $46,668 - $58,391
647 Added 0.13%
490,523 $43.4 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $69.4 Million - $83.4 Million
-1,101,374 Reduced 69.21%
489,876 $37.1 Million
Q2 2019

Aug 16, 2019

BUY
$65.7 - $83.98 $4.31 Million - $5.5 Million
65,546 Added 4.3%
1,591,250 $116 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $16.6 Million - $19.5 Million
215,009 Added 16.4%
1,525,704 $123 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1.77 Million - $2.18 Million
22,688 Added 1.76%
1,310,695 $121 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $690,652 - $767,789
-7,768 Reduced 0.6%
1,288,007 $122 Million
Q2 2018

Sep 27, 2018

BUY
$89.78 - $106.23 $115 Million - $136 Million
1,276,885 Added 6759.58%
1,295,775 $120 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $120 Million - $142 Million
-1,339,461 Reduced 98.61%
18,890 $851,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $59.2 Million - $79.3 Million
-643,233 Reduced 32.14%
1,358,351 $129 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $11.1 Million - $12.2 Million
-123,975 Reduced 5.83%
2,001,584 $194 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $148 Million - $190 Million
2,125,559
2,125,559 $189 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.